Patients with breast cancer and very low mammographic breast density have a poorer prognosis.
Very low mammographic breast density is associated with higher tumor grade and predicted worse survival, according to a study published in the journal European Radiology.
Researchers from Finland examined the prognostic value of mammographic breast density (MBD) and any relationship with established prognostic factors in patients with invasive breast cancer.
The study included 270 women with breast cancer. The researchers classified MBD according to percentile density: <5%, 5%–10%, 10%–25%, 25%–50%, 50%–75%, and >75%. The cases were also categorized into very low density (VLD; <10%), low density (LOD; <25%) and mixed density (MID; >25%).
The researchers found that MBD was inversely associated with tumor grade. Patients with LOD breasts had worse prognoses compared to those with MID breasts.
The strongest significance was seen among patients with VLD breasts compared to the remaining patients. No other mammographic feature was prognostically significant.
"It is difficult to detect small tumors when screening dense breasts, and this results in a higher occurrence of clinically detectable interval cancers,” Professor Ritva Vanninen, said in a release. “In the U.S., it is nowadays mandatory to let patients know if they have dense breast tissue. This allows them to choose whether they wish to have further tests, for example a screening ultrasound."
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.